|
Q4 2023
|
12 |
320,936 |
BIO, HCA, VPU, GLNG
|
13F-HR
|
2/14/2024 |
000135331624000002 |
|
Q3 2023
|
18 |
451,104 |
QQQ, BIO, VPU, MSFT
|
13F-HR
|
11/14/2023 |
000135331623000008 |
|
Q2 2023
|
16 |
440,668 |
BIO, QQQ, MSFT, FIS
|
13F-HR
|
8/14/2023 |
000135331623000005 |
|
Q1 2023
|
14 |
397,248 |
BIO, MSFT, QQQ, FIS
|
13F-HR
|
5/15/2023 |
000135331623000003 |
|
Q4 2022
|
13 |
338,192 |
HCA, QQQ, FRSH, MSFT
|
13F-HR
|
2/14/2023 |
000135331623000002 |
|
Q3 2022
|
16 |
526,733 |
IWM, VOO, HCA, MSFT
|
13F-HR
|
11/14/2022 |
000135331622000009 |
|
Q2 2022
|
24 |
1,232,697 |
VOO, IWM, MSFT, SPY
|
13F-HR
|
8/15/2022 |
000135331622000007 |
|
Q1 2022
|
31 |
1,547,269 |
VOO, IWM, KEX, MSFT
|
13F-HR
|
5/13/2022 |
000135331622000003 |
|
Q4 2021
|
111 |
1,777,410 |
VOO, IWM, KEX, MSFT
|
13F-HR
|
2/14/2022 |
000135331622000002 |
|
Q3 2021
|
210 |
1,880,177 |
VOO, MSFT, IWM, KEX
|
13F-HR
|
11/15/2021 |
000135331621000006 |
|
Q2 2021
|
252 |
2,067,066 |
VOO, KEX, FTCH, META
|
13F-HR
|
8/16/2021 |
000135331621000005 |
|
Q1 2021
|
251 |
2,117,675 |
VOO, FIS, META, KEX
|
13F-HR
|
5/17/2021 |
000135331621000004 |
|
Q4 2020
|
124 |
1,577,572 |
FTCH, HCA, KEX, WDAY
|
13F-HR
|
2/16/2021 |
000135331621000002 |
|
Q3 2020
|
98 |
1,476,251 |
FTCH, KEX, META, WDAY
|
13F-HR
|
11/16/2020 |
000135331620000010 |
|
Q2 2020
|
51 |
1,099,834 |
AER, META, W, MSFT
|
RESTATEMENT
|
8/17/2020 |
000135331620000008 |
|
Q1 2020
|
39 |
1,071,959 |
CARG, SATS, META, MSFT
|
13F-HR
|
5/15/2020 |
000135331620000005 |
|
Q4 2019
|
31 |
1,442,339 |
NXST, SATS, ARMK, META
|
13F-HR
|
2/14/2020 |
000135331620000003 |
|
Q3 2019
|
27 |
1,571,633 |
CARG, NXST, META, SPR
|
13F-HR
|
11/14/2019 |
000135331619000011 |
|
Q2 2019
|
31 |
2,048,517 |
CARG, RPM, SPR, META
|
13F-HR
|
8/14/2019 |
000135331619000010 |
|
Q1 2019
|
30 |
2,326,665 |
SPR, CARG, META, RPM
|
13F-HR
|
5/15/2019 |
000135331619000006 |
|
Q4 2018
|
29 |
3,112,251 |
TFCFA, SPR, META, HLT
|
13F-HR
|
2/14/2019 |
000135331619000002 |
|
Q3 2018
|
33 |
4,309,073 |
TFCFA, SPR, HLT, META
|
13F-HR
|
11/14/2018 |
000135331618000006 |
|
Q2 2018
|
21 |
4,179,189 |
TFCFA, SPR, META, HLT
|
13F-HR
|
8/14/2018 |
000135331618000005 |
|
Q1 2018
|
23 |
3,973,584 |
TFCFA, LKQ, MHK, CACC
|
13F-HR
|
5/15/2018 |
000135331618000003 |
|
Q4 2017
|
24 |
3,644,921 |
HLT, LKQ, SPR, EXPE
|
13F-HR
|
2/14/2018 |
000135331618000002 |
|
Q3 2017
|
25 |
4,205,128 |
HLT, SPR, EXPE, LKQ
|
13F-HR
|
11/14/2017 |
000135331617000011 |
|
Q2 2017
|
22 |
3,959,104 |
HLT, SPR, ANDV, LKQ
|
13F-HR
|
8/14/2017 |
000135331617000008 |
|
Q1 2017
|
25 |
3,932,656 |
HLT, SPR, ANDV, TMX
|
13F-HR
|
5/15/2017 |
000135331617000006 |
|
Q4 2016
|
26 |
4,142,579 |
HLT, SPR, ANDV, TMX
|
13F-HR
|
2/14/2017 |
000135331617000002 |
|
Q3 2016
|
28 |
3,712,549 |
SPR, ANDV, HLT, TMX
|
13F-HR
|
11/14/2016 |
000135331616000047 |
|
Q2 2016
|
20 |
3,756,682 |
C calls, SPR, ANDV, HLT
|
13F-HR
|
8/15/2016 |
000135331616000045 |
|
Q1 2016
|
24 |
3,679,939 |
C calls, SPR, BIDU, FLT
|
13F-HR
|
5/16/2016 |
000135331616000043 |
|
Q4 2015
|
21 |
4,408,076 |
C calls, SPR, BHC, FLT
|
13F-HR
|
2/16/2016 |
000135331616000038 |
|
Q3 2015
|
25 |
4,623,651 |
BHC, C calls, SPR, ANDV
|
13F-HR
|
11/16/2015 |
000135331615000033 |
|
Q2 2015
|
23 |
4,593,415 |
BHC, SPR, C calls, CRI
|
13F-HR
|
8/14/2015 |
000135331615000030 |
|
Q1 2015
|
28 |
4,524,095 |
VALEANT PHARMACEUTICALS INTL, SPR, C calls, CRI
|
13F-HR
|
5/15/2015 |
000135331615000025 |
|
Q4 2014
|
23 |
3,500,873 |
C calls, SPR, CRI, BHC
|
13F-HR
|
2/17/2015 |
000135331615000013 |
|
Q3 2014
|
20 |
3,155,267 |
BHC, C calls, CRI, SPR
|
13F-HR
|
11/14/2014 |
000135331614000016 |
|
Q2 2014
|
19 |
2,672,790 |
ANDV calls, BHC, CRI, LBRDA
|
13F-HR
|
8/12/2014 |
000135331614000011 |
|
Q1 2014
|
19 |
2,344,859 |
BHC, ANDV calls, CRI, LBRDA
|
13F-HR
|
5/12/2014 |
000135331614000004 |
|
Q4 2013
|
23 |
1,917,820 |
BHC, CRI, FLT, GRA
|
13F-HR
|
2/14/2014 |
000091957414001677 |